Loading
Life sciences · Journal article
Ejournal Kedokteran Indonesia · September 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
A 19-year-old female student presented to the university clinic following a hospital diagnosis of grade 1 fatty liver disease. The patient presents with grade 2 obesity, dyslipidemia, hyperuricemia, and elevated liver transaminases, compounded by a familial predisposition to obesity and type 2 diabetes mellitus. Given the patient's challenges regarding adherence to dietary and exercise recommendations, this evidence-based care report aims to investigate whether behavioral interventions, compared with standard care, more effectively facilitate clinical improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) among young adults. A literature search was conducted via PubMed® and Scopus® using keywords and Medical Subject Headings (MeSH) on June 23, 2026. Three systematic reviews, three randomized controlled trials, and one cohort study relevant to the clinical inquiries were selected and appraised for their validity, significance, and applicability. Clinical outcomes across six studies consistently demonstrate that behavioral interventions outperform standard care in weight management and the reduction of liver enzymes. These results are further enhanced by eHealth interventions. Improvements in lipid profiles were reported but exhibited heterogeneity. One study with a three-year follow-up period indicated improvements in the hepatic steatosis index (HSI) and fatty liver index (FLI) as measured by imaging, suggesting that longitudinal follow-up may reveal structural clinical enhancements.